Total Debt Disclosure
Abbott Laboratories, Statement of Financial Position, Debt
USD $ in thousands
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Short-term borrowings | 2,347,859 | 4,349,796 | 4,978,438 | 1,691,069 | 1,827,361 |
|
Current portion of long-term debt | 1,026,896 | 2,044,970 | 211,182 | 1,040,906 | 898,554 |
|
Long-term debt, excluding current portion | 12,039,822 | 12,523,517 | 11,266,294 | 8,713,327 | 9,487,789 |
|
Total debt | 15,414,577 | 18,918,283 | 16,455,914 | 11,445,302 | 12,213,704 |
| Item | Description | The company |
|---|---|---|
| Total debt | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Abbott Laboratories's total debt increased from 2009 to 2010 but then declined significantly from 2010 to 2011. |